
Sign up to save your podcasts
Or


Former executives from Valent Pharmaceuticals appear to be under investigation. Shares of Tronc fall 20% after Gannett walks away from its bid. Jim Gillies and Bill Barker discuss those stories, plus how Bath & Body Works is driving results for L Brands, and how scented candles are part of the plan. Chris Hill shares highlights (and lowlights) from the Marine Corps Marathon.
By The Motley Fool4.7
16041,604 ratings
Former executives from Valent Pharmaceuticals appear to be under investigation. Shares of Tronc fall 20% after Gannett walks away from its bid. Jim Gillies and Bill Barker discuss those stories, plus how Bath & Body Works is driving results for L Brands, and how scented candles are part of the plan. Chris Hill shares highlights (and lowlights) from the Marine Corps Marathon.

3,241 Listeners

1,501 Listeners

806 Listeners

944 Listeners

529 Listeners

1,189 Listeners

2,185 Listeners

825 Listeners

1,426 Listeners

1,053 Listeners

9,716 Listeners

194 Listeners

827 Listeners

83 Listeners

50 Listeners

1,034 Listeners

50 Listeners